Haijiao Zhang, M.D.

  • Assistant Professor of Division of Oncological Sciences, School of Medicine
  • OHSU Knight Cancer Institute, School of Medicine


Haijiao Zhang received her Bachelor and Master of Medicine degree from Jilin University in China and then earning an MD at Hannover Medical School in Germany. She joined Dr. Jeffrey Tyner’s laboratory as a postdoc in 2015 .The focus of her research in the Tyner lab has been oncogenic signaling and drug resistance mechanisms associated with hematologic malignancies. Between 2018 and 2019, Dr. Zhang embarked on a year-long visiting scholar opportunity in Dr. Ravi Majeti’s laboratory at Stanford University. In 2021, Dr. Zhang established her laboratory in the Division of Oncological Science at OHSU to study chromosome and copy number aberrations and WT1 in leukemia.

Education and training

    • B.Med., 2010, Jilin University
    • M.Med., 2012, Jilin University
    • D.Med., 2015, Hannover Medical School

Memberships and associations:

  • American Society of Hematology (ASH)
  • American Association for Cancer Research (AACR)
  • European Hematology Association (EHA)
  • Knight Cancer Institute Translational Oncology Research

Areas of interest

  • Leukemia
  • Wilm’s tumor gene isoforms and mutations
  • Chromosome and Copy Number Deletion
  • Drug biomarkers and resistance mechanism


Selected publications

  • https://www.ncbi.nlm.nih.gov/myncbi/1X5RFRFTfyjQh/bibliography/public/


  • {{ pub.journalAssociation.journal.name.text[0].value }}